News
Dexamethasone injection prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Nirmatrelvir + ritonavir added to COVID-19 Invitation for Expression of Interest (EOI)
Nirmatrelvir 150mg tablets + ritonavir 100mg tablets invited for COVID-19.
WHO list of prequalified in vitro diagnostic products updated
The WHO list of prequalified in vitro diagnostic products has been updated.
First misoprostol vaginal tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Report on the review of regulatory flexibilities/agilities as implemented by National Regulatory Authorities during Covid-19 pandemic
See full report:
First dolutegravir 10mg dispersible tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Newly prequalified Active Pharmaceutical Ingredient (API)
Ritonavir (WHOAPI-398) manufactured by Laurus Labs Limited has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) under its API prequalification procedure.
Cipla’s paediatric ritonavir tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Addition under section:
Baricitinib and sotrovimab invited for COVID-19
Baricitinib 2mg tablets and sotrovimab solution for infusion, 500 mg/8 mL (62.5 mg/mL) single use vial, invited for COVID-19.
Joint CIPAC/FAO/WHO Meeting on update information
Lupin’s moxifloxacin prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Joint UNICEF-UNFPA-WHO Meeting for Manufacturers and Suppliers - 08-10 March 2022
The World Health Organization (WHO), together with the United Nation’s Children Fund (UNICEF) and the United Nations Population Fund (UNFPA), will hold a three-day virtual meeting on 8-10 March 202
Consultant - In Vitro Diagnostics Assessment
Contractual Arrangement: External consultant
Contract Duration: 8 months
Job Posting: Nov 15, 2021, 7:46:07 PM
WHO list of prequalified in vitro diagnostic products updated
The WHO list of prequalified in vitro diagnostic products has been updated.
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Addition under section:
WHO list of prequalified in vitro diagnostic products updated
The WHO list of prequalified in vitro diagnostic products has been updated.
Molnupiravir invited for COVID-19
Molnupiravir 200 mg capsules for oral administration invited for COVID-19.
WHO list of prequalified in vitro diagnostic products updated
The WHO list of prequalified in vitro diagnostic products has been updated.
ACME Lab’s dispersible zinc tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
PT Sanbe’s levofloxacin tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Micro Labs’ paediatric ethambutol prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: